Ind-Swift Laboratories to incorporate wholly owned subsidiary in UAE

19 Apr 2024 Evaluate

Ind-Swift Laboratories has received approval to incorporate wholly owned subsidiary (WOS) in Dubai, United Arab Emirates (UAE) in the name and style of ‘Ind-Swift (Dubai)’ or such other name as may be approved by the concerned authorities of the UAE. 

The WOS intends to strategically invest in pharmaceutical and allied activities. This includes exploring potential acquisitions, tie-ups, or joint ventures. Additionally, the Company aims to establish and operate pharmaceutical manufacturing units. The investment in the wholly owned subsidiary would be a Related Party Transaction. The investment shall be made on arms’ Length basis.

Ind-Swift Laboratories is global manufacturer of Active Pharmaceutical Ingredients (API), Intermediates and formulations (through group collaboration).


Ind-Swift Lab. Share Price

85.96 -5.79 (-6.31%)
04-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1709.40
Dr. Reddys Lab 1109.75
Cipla 1415.55
Lupin 1971.10
Zydus Lifesciences 866.65
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...